Aulwurm S - Search Results

1

Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.

Hofmann M, Große-Hovest L, Nübling T, Pyż E, Bamberg ML, Aulwurm S, Bühring HJ, Schwartz K, Haen SP, Schilbach K, Rammensee HG, Salih HR, Jung G. Hofmann M, et al. Among authors: aulwurm s. Leukemia. 2012 Jun;26(6):1228-37. doi: 10.1038/leu.2011.372. Epub 2012 Jan 6. Leukemia. 2012. PMID: 22289926

2

Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody.

Seidel UJ, Schlegel P, Grosse-Hovest L, Hofmann M, Aulwurm S, Pyz E, Schuster FR, Meisel R, Ebinger M, Feuchtinger T, Teltschik HM, Witte KE, Schwarze CP, Rammensee HG, Handgretinger R, Jung G, Lang P. Seidel UJ, et al. Among authors: aulwurm s. Mol Ther. 2016 Sep;24(9):1634-43. doi: 10.1038/mt.2016.141. Epub 2016 Jul 6. Mol Ther. 2016. PMID: 27380762 Free PMC article.

3

MICA/NKG2D-mediated immunogene therapy of experimental gliomas.

Friese MA, Platten M, Lutz SZ, Naumann U, Aulwurm S, Bischof F, Bühring HJ, Dichgans J, Rammensee HG, Steinle A, Weller M. Friese MA, et al. Among authors: aulwurm s. Cancer Res. 2003 Dec 15;63(24):8996-9006. Cancer Res. 2003. PMID: 14695218

4

Therapeutic anti-tumor immunity triggered by injections of immunostimulating single-stranded RNA.

Scheel B, Aulwurm S, Probst J, Stitz L, Hoerr I, Rammensee HG, Weller M, Pascolo S. Scheel B, et al. Among authors: aulwurm s. Eur J Immunol. 2006 Oct;36(10):2807-16. doi: 10.1002/eji.200635910. Eur J Immunol. 2006. PMID: 17013976 Free article.

5

SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.

Uhl M, Aulwurm S, Wischhusen J, Weiler M, Ma JY, Almirez R, Mangadu R, Liu YW, Platten M, Herrlinger U, Murphy A, Wong DH, Wick W, Higgins LS, Weller M. Uhl M, et al. Among authors: aulwurm s. Cancer Res. 2004 Nov 1;64(21):7954-61. doi: 10.1158/0008-5472.CAN-04-1013. Cancer Res. 2004. PMID: 15520202

6

Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo.

Aulwurm S, Wischhusen J, Friese M, Borst J, Weller M. Aulwurm S, et al. Int J Cancer. 2006 Apr 1;118(7):1728-35. doi: 10.1002/ijc.21544. Int J Cancer. 2006. PMID: 16217761 Free article.

7

Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas.

Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S, Weller M. Platten M, et al. Among authors: aulwurm s. Ann Neurol. 2003 Sep;54(3):388-92. doi: 10.1002/ana.10679. Ann Neurol. 2003. PMID: 12953273

8

MIP-1alpha antagonizes the effect of a GM-CSF-enhanced subcutaneous vaccine in a mouse glioma model.

Herrlinger U, Aulwurm S, Strik H, Weit S, Naumann U, Weller M. Herrlinger U, et al. Among authors: aulwurm s. J Neurooncol. 2004 Jan;66(1-2):147-54. doi: 10.1023/b:neon.0000013497.04322.fc. J Neurooncol. 2004. PMID: 15015780

9

Regeneration and tolerance factor: a novel mediator of glioblastoma-associated immunosuppression.

Roth P, Aulwurm S, Gekel I, Beier D, Sperry RG, Mittelbronn M, Meyermann R, Beaman KD, Weller M, Wischhusen J. Roth P, et al. Among authors: aulwurm s. Cancer Res. 2006 Apr 1;66(7):3852-8. doi: 10.1158/0008-5472.CAN-05-3062. Cancer Res. 2006. PMID: 16585213

10

Glioma gene therapy with soluble transforming growth factor-beta receptors II and III.

Naumann U, Maass P, Gleske AK, Aulwurm S, Weller M, Eisele G. Naumann U, et al. Among authors: aulwurm s. Int J Oncol. 2008 Oct;33(4):759-65. Int J Oncol. 2008. PMID: 18813789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page